In Vitro Diagnostics (IVD) Quality Control Market

In Vitro Diagnostics (IVD) Quality Control Market by Source (Serum, Whole Blood, Urine), Application (Immunoassay, Hematology, Microbiology), Type (Independent Controls, Original Equipment Manufacturers), End User (Hospital, Lab) - Global Forecast to 2025

Report Code: MD 4180 Mar, 2020, by marketsandmarkets.com
COVID-19

Get in-depth analysis of how COVID-19 is impacting the In Vitro Diagnostics (IVD) Quality Control Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the In Vitro Diagnostics (IVD) Quality Control Market

Request Now

The global IVD quality control market is expected to reach USD 1,158 million by 2025 from an estimated value of USD 961 Million in 2020, growing at a CAGR of 3.8% during the forecast period. The market for global IVD quality control is primarily driven by the rising number of accredited clinical laboratories, increasing demand for third-party quality controls, and rising prevalence of chronic and infectious diseases. However, additional cost and budget constraints in hospitals & laboratories will restrain the market growth.

In Vitro Diagnostics (IVD) Quality Control Market

The third-party controls segment is projected to grow at the highest CAGR during the forecast period

On the basis of manufacturer, the IVD quality control market is segmented into third-party controls and original equipment manufacturers (OEMs) controls. The third-party controls segment accounted for the largest market share in 2019. The large share of this segment is mainly attributed to the rising demand for third-party quality controls due to their unbiased test results.

In 2019, the immunoassay/immunochemistry segment accounted for the largest share of the market

On the basis of application, the market is segmented into clinical chemistry, immunochemistry, hematology, coagulation & hemostasis, microbiology, molecular diagnostics, and other applications (ESR, urine chemistry, immunology, cardiac assessment, and blood morphology). The immunochemistry segment accounted for the largest share of the market in 2019. The large share of this segment is primarily attributed to the increasing use of multi-analyte controls to perform immunoassay tests in laboratories.

In Vitro Diagnostics (IVD) Quality Control Market

North America accounted for the largest share of the IVD quality control market in 2019

The market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the market. The factors such as the increasing number of IVD tests; growing need for ensuring the accuracy and reliability of test results; and the rising use of third-party quality controls among clinical laboratories in this region are driving the growth of the market in this region.

Key Market Players

The key players in the global IVD quality control market are Bio-Rad Laboratories Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific Inc. (US), Technopath Clinical Diagnostics (Ireland), Bio-Techne Corporation (US), Fortress Diagnostics (UK), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), SeraCare Life Sciences Inc. (US), Abbott Laboratories Inc. (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics, Inc. (US), and Helena Laboratories (US)

Bio-Rad Laboratories Inc. (US) is one of the leading players in the market and accounted for the largest share in 2018. KRάSS is one of the leading providers of third party quality controls including liquid & lyophilized controls, data management solutions and quality assurance services. To strengthen its market position and to broaden its product offerings, the company majorly focuses on product launch. For example, in January 2018, the company launched Liquichek Serum Indices to check an instrument’s ability to detect hemolysis, icterus, and lipemia (HIL) specimen interferences in patient samples.

Randox Laboratories Ltd. (UK) held the second-largest share in the market in 2018. The company offers a robust portfolio of true third-party quality control solutions. To sustain its strong position in the market, the company focuses on strengthening its quality control product offerings through organic strategies, such as product launches. For instance, in July 2019, the company launched Whole-pathogen Blood Borne Virus (BBV) controls to help molecular laboratories effectively manage assay performance.

Scope of the Report:

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD)

Segments covered

Product & Service, Application, Manufacturer, End User, and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Companies covered

Bio-Rad Laboratories Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific Inc. (US), Technopath Clinical Diagnostics (Ireland), Bio-Techne Corporation (US), Fortress Diagnostics (UK), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), SeraCare Life Sciences Inc. (US), Abbott Laboratories Inc. (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics, Inc. (US), and Helena Laboratories (US)..
Total 25 major players covered

The research report categorizes the market into the following segments and subsegments:

By Product & Service

  • Quality Control Products
  • Serum/Plasma-Based Controls
  • Whole Blood-Based Controls
  • Urine-Based Controls
  • Other Source-Based IVD Quality Controls
  • Data Management Solutions
  • Quality Assurance Services

By Application

  • Immunochemistry/Immunoassay
  • Clinical Chemistry
  • Hematology
  • Molecular Diagnostics
  • Coagulation & Hemostasis
  • Microbiology
  • Other Applications

By Manufacturer

  • Third-Party Control Manufacturers
  • Independent Controls
  • Instrument-Specific Controls
  • Original Equipment Manufacturers (OEMS)

By End User

  • Hospitals
  • Clinical Laboratories
  • Academic & Research Institutes
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLA)
  • Middle East & Africa

Recent Developments

  • In December 2019, Technopath Clinical Diagnostics (Ireland) and Data Innovations LLC (US) partnered to offer a robust portfolio of quality control data management solutions to their customers.
  • In October 2019, Thermo Fisher Scientific (US) launched Acrometrix BCR-ABL Panel, a new external molecular quality control panel for the analytical validation of BCR-ABL test methods.
  • In March 2018, Technopath Clinical Diagnostics (Ireland) and Beckman Coulter Inc. (US) entered into a supply and distribution agreement wherein Technopath supplied its Multichem QC products and IAMQC data management solutions to Beckman Coulter and allowed it to distribute its QC products in more than 100 countries.
  • In February 2018, Qnostics (UK) and Randox Laboratories Ltd. (UK) entered into a partnership wherein Randox Laboratories to sell and distribute Qnostics’ molecular range of products, which strengthened Qnostics’ market penetration.
  • In January 2018, Technopath Clinical Diagnostics (Ireland) launched Multichem AMH quality control, a liquid frozen quality control material.

Critical questions the report answers:

  • Where will all the developments take the industry in the mid-to-long term?
  • What are the major industries and the benefits they avail by using quality control products?
  • What are the trends going on in the global IVD quality control market?
  • What are the major market dynamics and their impact on market growth?
  • What is the global scenario of the market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 22)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Inclusions and Exclusions
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 25)
    2.1 Research Approach
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation

3 Executive Summary (Page No. - 32)

4 Premium Insights (Page No. - 38)
    4.1 IVD Quality Control: Market Overview
    4.2 APAC: IVD Quality Control Market, By Technology (2019)
    4.3 Geographic Snapshot of the Market
    4.4 Regional Mix: Market
    4.5 Market: Developing Vs. Developed Markets

5 Market Overview (Page No. - 42)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Number of Accredited Clinical Laboratories
                    5.2.1.2 Growing Adoption of Third-Party Quality Controls
                    5.2.1.3 Rising Demand for External Quality Assessment Support
                    5.2.1.4 Increasing Prevalence of Chronic and Infectious Diseases
           5.2.2 Market Restraints
                    5.2.2.1 Additional Costs and Budget Constraints in Hospitals and Laboratories
                    5.2.2.2 Unfavorable Reimbursement Scenario for IVD Tests
           5.2.3 Market Opportunities
                    5.2.3.1 Rising Demand for Multi-Analyte Controls
           5.2.4 Challenges
                    5.2.4.1 Stringent Product Approval Process
                    5.2.4.2 Lack of Regulations for Clinical Laboratory Accreditation in Several Emerging Countries

6 Industry Insights (Page No. - 48)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Lyophilize/Freeze-Dried Controls
           6.2.2 Trends on Analyte Source: Human Vs. Animal Origin
           6.2.3 Consolidation of Laboratories
    6.3 Vendor Benchmarking
           6.3.1 Product Portfolio Analysis: IVD Quality Control Market
    6.4 Regulatory Analysis
           6.4.1 North America
                    6.4.1.1 US
                    6.4.1.2 Canada
           6.4.2 Europe
           6.4.3 Asia Pacific
                    6.4.3.1 Japan
                    6.4.3.2 China
                    6.4.3.3 India

7 IVD Quality Control Market, By Product & Service (Page No. - 57)
    7.1 Introduction
    7.2 Quality Control Products
           7.2.1 Serum/Plasma-Based Controls
                    7.2.1.1 Greater Stability and Accuracy of Diagnostic Test Results Will Increase the Demand for Serum/Plasma-Based Controls
           7.2.2 Whole Blood-Based Controls
                    7.2.2.1 Rising Need to Ensure High-Quality Clinical Test Results is Driving the Market for Whole Blood-Based Controls
           7.2.3 Urine-Based Controls
                    7.2.3.1 Growing Incidence of Kidney Diseases Will Increase the Need for Urine-Based Controls
           7.2.4 Other Controls
    7.3 Data Management Solutions
           7.3.1 Rising Focus on Improving the Analytical Performance of Clinical Laboratories Supports Market Growth
    7.4 Quality Assurance Services
           7.4.1 Growing Need for Performance Assessment of Clinical Laboratories Will Increase the Demand for Quality Assurance Services

8 IVD Quality Control Market, By Technology (Page No. - 72)
    8.1 Introduction
    8.2 Immunochemistry
           8.2.1 Focus on Monitoring the Precision of Immunoassay Tests is Driving the Adoption of Immunoassay Controls
    8.3 Clinical Chemistry
           8.3.1 Rising Incidence of Lifestyle Diseases Provides Opportunities for Market Growth
    8.4 Molecular Diagnostics
           8.4.1 Growing Incidence of Infectious Diseases Will Drive Demand for Molecular Diagnostic Controls
    8.5 Microbiology
           8.5.1 Increasing Adoption of Automated Clinical Microbiology Testing Instruments is Supporting Market Growth
    8.6 Hematology
           8.6.1 Need for Accuracy in Hematological Test Results has Driven Reliance on Hematology Quality Controls
    8.7 Coagulation & Hemostasis
           8.7.1 Growing Number of Cardiovascular Surgeries Will Increase Need for Coagulation & Hemostasis Testing
    8.8 Other Technologies

9 IVD Quality Control Market, By Manufacturer (Page No. - 86)
    9.1 Introduction
    9.2 Third-Party Controls
           9.2.1 Independent Controls
                    9.2.1.1 Increasing Preference for Independent Controls Fuels Market Growth
           9.2.2 Instrument-Specific Controls
                    9.2.2.1 Usage Limitations Have Subdued Market Growth Rate in Favor of Independent Controls
    9.3 Original Equipment Manufacturer Controls
           9.3.1 OEM Controls are Less-Sensitive to Qc-Related Issues, Which has Resulted in Lower Adoption

10 IVD Quality Control Market, By End User (Page No. - 95)
     10.1 Introduction
     10.2 Hospitals
             10.2.1 Huge Volume of IVD Procedures Performed in Hospitals are Driving Market Growth
     10.3 Clinical Laboratories
             10.3.1 Growing Number of Accredited Laboratories Will Drive the Market
     10.4 Academic and Research Institutes
             10.4.1 Rising Focus on Obtaining Accurate Research Findings is Driving Market Growth
     10.5 Other End Users

11 IVD Quality Control Market, By Region (Page No. - 102)
     11.1 Introduction
     11.2 North America
             11.2.1 US
                       11.2.1.1 US is the Largest Market for IVD Quality Control in North America
             11.2.2 Canada
                       11.2.2.1 Government Initiatives to Promote Quality Controls are Expected to Drive Market Growth in Canada
     11.3 Europe
             11.3.1 Germany
                       11.3.1.1 Germany is a Major Market for IVD Quality Control Products in Europe
             11.3.2 France
                       11.3.2.1 Increasing Prevalence of Infectious Diseases and Growing Demand for Early Diagnosis is Driving Market Growth
             11.3.3 UK
                       11.3.3.1 Growth in the Country’s Life Science Industry and Increasing Research are Key Factors Driving Market Growth in the UK
             11.3.4 Italy
                       11.3.4.1 Growing Disease Prevalence has Contributed to the Demand for Better and Accurate Disease Diagnosis in Italy
             11.3.5 Spain
                       11.3.5.1 Increasing Demand for Prenatal and Genetic Testing and Rising Focus on Laboratory Consolidation Support Market Growth in Spain
             11.3.6 Russia
                       11.3.6.1 Increasing Incidence of Lifestyle Diseases Will Create a Need for Accurate Diagnosis
             11.3.7 Rest of Europe
     11.4 Asia Pacific
             11.4.1 Japan
                       11.4.1.1 Japan Held the Largest Share of the Market in the APAC
             11.4.2 China
                       11.4.2.1 Growing Access to Modern Healthcare and Government Support Will Boost Market Growth
             11.4.3 India
                       11.4.3.1 Rising Need to Secure Nabl Accreditation Will Increase the Demand for Quality Controls in India
             11.4.4 Australia
                       11.4.4.1 Rising Burden of Geriatric Population has Resulted in Initiatives to Enhance Access to Healthcare and Improve Infrastructure
             11.4.5 South Korea
                       11.4.5.1 Rising Healthcare Expenditure and the Growing Number of Hospitals are Driving the Growth of the South Korean Market
             11.4.6 Rest of Asia Pacific
     11.5 Latin America
             11.5.1 Brazil
                       11.5.1.1 Brazil Dominates the Latin American IVD Quality Control Market
             11.5.2 Mexico
                       11.5.2.1 Mexico is Emerging as a Prominent Medical Tourism Hub
             11.5.3 Rest of Latin America
     11.6 Middle East and Africa
             11.6.1 Rising Cancer Incidence has Attracted Stakeholder Attention to Regional Markets in Mea

12 Competitive Landscape (Page No. - 163)
     12.1 Overview
     12.2 Market Ranking Analysis
     12.3 Market Ranking Analysis for External Quality Assessment Services in 2018
     12.4 Competitive Leadership Mapping
             12.4.1 Visionary Leaders
             12.4.2 Innovators
             12.4.3 Dynamic Differentiators
             12.4.4 Emerging Companies
     12.5 Competitive Situation and Trends
             12.5.1 Product Launches
             12.5.2 Agreements and Partnerships
             12.5.3 Expansions

13 Company Profiles (Page No. - 170)
     13.1 Bio-Rad Laboratories
             13.1.1 Business Overview
             13.1.2 Products and Services Offered
             13.1.3 Recent Developments
             13.1.4 MnM View
     13.2 Randox Laboratories
             13.2.1 Business Overview
             13.2.2 Products and Services Offered
             13.2.3 Recent Developments
             13.2.4 MnM View
     13.3 Thermo Fisher Scientific
             13.3.1 Business Overview
             13.3.2 Products Offered
             13.3.3 Recent Developments
             13.3.4 MnM View
     13.4 Roche Diagnostics
             13.4.1 Business Overview
             13.4.2 Products Offered
     13.5 Helena Laboratories
             13.5.1 Business Overview
             13.5.2 Products Offered
     13.6 SeraCare Life Sciences
             13.6.1 Business Overview
             13.6.2 Products Offered
     13.7 SERO AS
             13.7.1 Business Overview
             13.7.2 Products Offered
     13.8 Ortho Clinical Diagnostics
             13.8.1 Business Overview
             13.8.2 Products Offered
     13.9 Sun Diagnostics
             13.9.1 Business Overview
             13.9.2 Products Offered
     13.10 Quidel Corporation
               13.10.1 Business Overview
               13.10.2 Products Offered
     13.11 Technopath Clinical Diagnostics
               13.11.1 Business Overview
               13.11.2 Products Offered
               13.11.3 Recent Developments
     13.12 Abbott Laboratories
               13.12.1 Business Overview
               13.12.2 Products Offered
     13.13 Danaher Corporation
               13.13.1 Business Overview
               13.13.2 Products Offered
     13.14 Sysmex Corporation
               13.14.1 Business Overview
               13.14.2 Products Offered
     13.15 Siemens Healthineers
               13.15.1 Business Overview
               13.15.2 Products Offered
               13.15.3 Recent Developments
     13.16 Fortress Diagnostics
               13.16.1 Business Overview
               13.16.2 Products Offered
               13.16.3 Recent Developments
     13.17 Zeptometrix Corporation
               13.17.1 Business Overview
               13.17.2 Products Offered
               13.17.3 Recent Developments
     13.18 Qnostics
               13.18.1 Business Overview
               13.18.2 Products Offered
               13.18.3 Recent Developments
     13.19 Bio-Techne Corporation
               13.19.1 Business Overview
               13.19.2 Products Offered
               13.19.3 Recent Developments
     13.20 Microbiologics
               13.20.1 Business Overview
               13.20.2 Products Offered
               13.20.3 Recent Developments

14 Appendix (Page No. - 218)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Available Customizations
     14.5 Related Reports
     14.6 Author Details


List of Tables (195 Tables)

Table 1 Global IVD Quality Control Market Snapshot
Table 2 Market Dynamics: Impact Analysis
Table 3 Number of People With Diabetes, By Region, 2019 Vs. 2030 (Million Individuals)
Table 4 Lyophilized or Freeze-Dried Quality Controls Offered By Key Market Players
Table 5 US: Classification of Quality Control Material
Table 6 US: Time, Cost, and Complexity of Registration
Table 7 Canada: Classification of IVD Products
Table 8 Canada: Time, Cost, and Complexity of Registration
Table 9 Europe: Accreditation Bodies for Medical Laboratories
Table 10 Europe: Time, Cost, and Complexity of Registration
Table 11 Japan: Time, Cost, and Complexity of Registration
Table 12 China: Time, Cost, and Complexity of Registration
Table 13 India: Time, Cost, and Complexity of Registration
Table 14 IVD Quality Control Market, By Product & Service, 2018–2025 (USD Million)
Table 15 Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 16 Quality Control Products Market, By Country, 2018–2025 (USD Million)
Table 17 Serum/Plasma-Based Quality Controls Offered By Key Market Players
Table 18 Serum/Plasma-Based Quality Control Products Market, By Country, 2018–2025 (USD Million)
Table 19 Whole Blood-Based Quality Controls Offered By Key Market Players
Table 20 Whole Blood-Based Quality Control Products Market, By Country, 2018–2025 (USD Million)
Table 21 Urine-Based IVD Controls Offered By Key Market Players
Table 22 Urine-Based Quality Control Products Market, By Country, 2018–2025 (USD Million)
Table 23 Other Controls Offered By Key Market Players
Table 24 Other Quality Control Products Market, By Country, 2018–2025 (USD Million)
Table 25 Data Management Solutions Offered By Key Market Players
Table 26 Data Management Solutions Market, By Country, 2018–2025 (USD Million)
Table 27 Quality Assurance Services Offered By Key Market Players
Table 28 Quality Assurance Services Market, By Country, 2018–2025 (USD Million)
Table 29 IVD Quality Control Market, By Technology, 2018–2025 (USD Million)
Table 30 Quality Controls for Immunochemistry Offered By Key Market Players
Table 31 Market for Immunochemistry, By Country, 2018–2025 (USD Million)
Table 32 Quality Controls for Clinical Chemistry Offered By Key Market Players
Table 33 Market for Clinical Chemistry, By Country, 2018–2025 (USD Million)
Table 34 Quality Controls for Molecular Diagnostics Offered By Key Market Players
Table 35 Market for Molecular Diagnostics, By Country, 2018–2025 (USD Million)
Table 36 Quality Controls for Microbiology Offered By Key Market Players
Table 37 Market for Microbiology, By Country, 2018–2025 (USD Million)
Table 38 Quality Controls for Hematology Offered By Key Market Players
Table 39 Market for Hematology, By Country, 2018–2025 (USD Million)
Table 40 Quality Controls for Coagulation & Hemostasis Offered By Key Market Players
Table 41 IVD Quality Control Market for Coagulation and Hemostasis, By Country, 2018–2025 (USD Million)
Table 42 Quality Controls for Other Technologies Offered By Key Market Players
Table 43 Market for Other Technologies, By Country, 2018–2025 (USD Million)
Table 44 Market, By Manufacturer, 2018–2025 (USD Million)
Table 45 Third-Party Control Market, By Type, 2018–2025 (USD Million)
Table 46 Third-Party Market, By Country, 2018–2025 (USD Million)
Table 47 Independent Controls Offered By Key Market Players
Table 48 Independent Third-Party Control Market, By Country, 2018–2025 (USD Million)
Table 49 Instrument-Specific Controls Offered By Key Market Players
Table 50 Instrument-Specific Third-Party Control Market, By Country, 2018–2025 (USD Million)
Table 51 OEM Controls Offered By Key Market Players
Table 52 Original Equipment Manufacturer Control Market, By Country, 2018–2025 (USD Million)
Table 53 Market, By End User, 2018–2025 (USD Million)
Table 54 Market for Hospitals, By Country, 2018–2025 (USD Million)
Table 55 Market for Clinical Laboratories, By Country, 2018–2025 (USD Million)
Table 56 IVD Quality Control Market for Academic & Research Institutes, By Country, 2018–2025 (USD Million)
Table 57 Market for Other End Users, By Country, 2018–2025 (USD Million)
Table 58 Market, By Region, 2018–2025 (USD Million)
Table 59 Market, By Country, 2018–2025 (USD Million)
Table 60 North America: Market, By Country, 2018–2025 (USD Million)
Table 61 North America: Market, By Product & Service, 2018–2025 (USD Million)
Table 62 North America: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 63 North America: Market, By Technology, 2018–2025 (USD Million)
Table 64 North America: Market, By End User, 2018–2025 (USD Million)
Table 65 North America: IVD Quality Control Market, By Manufacturer, 2018–2025 (USD Million)
Table 66 US: Key Macroindicators
Table 67 US: trol Market, By Product & Service, 2018–2025 (USD Million)
Table 68 US: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 69 US: Market, By Technology, 2018–2025 (USD Million)
Table 70 US: Market, By End User, 2018–2025 (USD Million)
Table 71 US: Market, By Manufacturer, 2018–2025 (USD Million)
Table 72 Canada: Key Macroindicators
Table 73 Canada: Market, By Product & Service, 2018–2025 (USD Million)
Table 74 Canada: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 75 Canada: IVD Quality Control Market, By Technology, 2018–2025 (USD Million)
Table 76 Canada: Market, By End User, 2018–2025 (USD Million)
Table 77 Canada: Market, By Manufacturer, 2018–2025 (USD Million)
Table 78 Europe: Market, By Country, 2018–2025 (USD Million)
Table 79 Europe: IVD Quality Control Market, By Product & Service, 2018–2025 (USD Million)
Table 80 Europe: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 81 Europe: Market, By Technology, 2018–2025 (USD Million)
Table 82 Europe: Market, By End User, 2018–2025 (USD Million)
Table 83 Europe: Market, By Manufacturer, 2018–2025 (USD Million)
Table 84 Germany: Key Macroindicators
Table 85 Germany: Market, By Product & Service, 2018–2025 (USD Million)
Table 86 Germany: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 87 Germany: Market, By Technology, 2018–2025 (USD Million)
Table 88 Germany: Market, By End User, 2018–2025 (USD Million)
Table 89 Germany: Market, By Manufacturer, 2018–2025 (USD Million)
Table 90 France: Key Macroindicators
Table 91 France: Market, By Product & Service, 2018–2025 (USD Million)
Table 92 France: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 93 France: Market, By Technology, 2018–2025 (USD Million)
Table 94 France: Market, By End User, 2018–2025 (USD Million)
Table 95 France: Market, By Manufacturer, 2018–2025 (USD Million)
Table 96 UK: Key Macroindicators
Table 97 UK: Market, By Product & Service, 2018–2025 (USD Million)
Table 98 UK: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 99 UK: Market, By Technology, 2018–2025 (USD Million)
Table 100 UK: Market, By End User, 2018–2025 (USD Million)
Table 101 UK: Market, By Manufacturer, 2018–2025 (USD Million)
Table 102 Italy: Key Macroindicators
Table 103 Italy: Market, By Product & Service, 2018–2025 (USD Million)
Table 104 Italy: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 105 Italy: IVD Quality Control Market, By Technology, 2018–2025 (USD Million)
Table 106 Italy: Market, By End User, 2018–2025 (USD Million)
Table 107 Italy: Market, By Manufacturer, 2018–2025 (USD Million)
Table 108 Spain: Key Macroindicators
Table 109 Spain: Market, By Product & Service, 2018–2025 (USD Million)
Table 110 Spain: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 111 Spain: Market, By Technology, 2018–2025 (USD Million)
Table 112 Spain: Market, By End User, 2018–2025 (USD Million)
Table 113 Spain: Market, By Manufacturer, 2018–2025 (USD Million)
Table 114 Russia: Key Macroindicators
Table 115 Russia: Market, By Product & Service, 2018–2025 (USD Million)
Table 116 Russia: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 117 Russia: Market, By Technology, 2018–2025 (USD Million)
Table 118 Russia: Market, By End User, 2018–2025 (USD Million)
Table 119 Russia: Market, By Manufacturer, 2018–2025 (USD Million)
Table 120 RoE: Market, By Product & Service, 2018–2025 (USD Million)
Table 121 RoE: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 122 RoE: Market, By Technology, 2018–2025 (USD Million)
Table 123 RoE: Market, By End User, 2018–2025 (USD Million)
Table 124 RoE: IVD Quality Control Market, By Manufacturer, 2018–2025 (USD Million)
Table 125 Asia Pacific: Market, By Country, 2018–2025 (USD Million)
Table 126 Asia Pacific: Market, By Product & Service, 2018–2025 (USD Million)
Table 127 Asia Pacific: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 128 Asia Pacific: Market, By Technology, 2018–2025 (USD Million)
Table 129 Asia Pacific: Market, By End User, 2018–2025 (USD Million)
Table 130 Asia Pacific: Market, By Manufacturer, 2018–2025 (USD Million)
Table 131 Japan: Key Macroindicators
Table 132 Japan: Market, By Product & Service, 2018–2025 (USD Million)
Table 133 Japan: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 134 Japan: Market, By Technology, 2018–2025 (USD Million)
Table 135 Japan: Market, By End User, 2018–2025 (USD Million)
Table 136 Japan: Market, By Manufacturer, 2018–2025 (USD Million)
Table 137 China: Key Macroindicators
Table 138 China: Market, By Product & Service, 2018–2025 (USD Million)
Table 139 China: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 140 China: Market, By Technology, 2018–2025 (USD Million)
Table 141 China: Market, By End User, 2018–2025 (USD Million)
Table 142 China: Market, By Manufacturer, 2018–2025 (USD Million)
Table 143 India: Key Macroindicators
Table 144 India: IVD Quality Control Market, By Product & Service, 2018–2025 (USD Million)
Table 145 India: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 146 India: Market, By Technology, 2018–2025 (USD Million)
Table 147 India: Market, By End User, 2018–2025 (USD Million)
Table 148 India: Market, By Manufacturer, 2018–2025 (USD Million)
Table 149 Australia: Key Macroindicators
Table 150 Australia: Market, By Product & Service, 2018–2025 (USD Million)
Table 151 Australia: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 152 Australia: IVD Quality Control Market, By Technology, 2018–2025 (USD Million)
Table 153 Australia: Market, By End User, 2018–2025 (USD Million)
Table 154 Australia: Market, By Manufacturer, 2018–2025 (USD Million)
Table 155 South Korea: Market, By Product & Service, 2018–2025 (USD Million)
Table 156 South Korea: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 157 South Korea: Market, By Technology, 2018–2025 (USD Million)
Table 158 South Korea: Market, By End User, 2018–2025 (USD Million)
Table 159 South Korea: Market, By Manufacturer, 2018–2025 (USD Million)
Table 160 RoAPAC: IVD Quality Control Market, By Product & Service, 2018–2025 (USD Million)
Table 161 RoAPAC: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 162 RoAPAC: Market, By Technology, 2018–2025 (USD Million)
Table 163 RoAPAC: Market, By End User, 2018–2025 (USD Million)
Table 164 RoAPAC: Market, By Manufacturer, 2018–2025 (USD Million)
Table 165 Latin America: Market, By Country, 2018–2025 (USD Million)
Table 166 Latin America: Market, By Product & Service, 2018–2025 (USD Million)
Table 167 Latin America: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 168 Latin America: Market, By Technology, 2018–2025 (USD Million)
Table 169 Latin America: Market, By End User, 2018–2025 (USD Million)
Table 170 Latin America: Market, By Manufacturer, 2018–2025 (USD Million)
Table 171 Brazil: Key Macroindicators
Table 172 Brazil: IVD Quality Control Market, By Product & Service, 2018–2025 (USD Million)
Table 173 Brazil: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 174 Brazil: Market, By Technology, 2018–2025 (USD Million)
Table 175 Brazil: Market, By End User, 2018–2025 (USD Million)
Table 176 Brazil: Market, By Manufacturer, 2018–2025 (USD Million)
Table 177 Mexico: Key Macroindicators
Table 178 Mexico: Market, By Product & Service, 2018–2025 (USD Million)
Table 179 Mexico: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 180 Mexico: Market, By Technology, 2018–2025 (USD Million)
Table 181 Mexico: Market, By End User, 2018–2025 (USD Million)
Table 182 Mexico: Market, By Manufacturer, 2018–2025 (USD Million)
Table 183 RoLA: Market, By Product & Service, 2018–2025 (USD Million)
Table 184 RoLA: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 185 RoLA: IVD Quality Control Market, By Technology, 2018–2025 (USD Million)
Table 186 RoLA: Market, By End User, 2018–2025 (USD Million)
Table 187 RoLA: Market, By Manufacturer, 2018–2025 (USD Million)
Table 188 Middle East & Africa: Market, By Product & Service, 2018–2025 (USD Million)
Table 189 Middle East & Africa: IVD Quality Control Products Market, By Type, 2018–2025 (USD Million)
Table 190 Middle East & Africa: Market, By Technology, 2018–2025 (USD Million)
Table 191 Middle East & Africa: Market, By End User, 2018–2025 (USD Million)
Table 192 Middle East & Africa: Market, By Manufacturer, 2018–2025 (USD Million)
Table 193 Product Launches, 2018–2019
Table 194 Agreements and Partnerships, 2018–2019
Table 195 Expansions, 2018–2019
 
 
List of Figures (38 Figures)
 
Figure 1 Research Design
Figure 2 Market Size Approach
Figure 3 Top-Down Approach
Figure 4 Data Triangulation Methodology
Figure 5 Assumptions of the Study
Figure 6 IVD Quality Control Market, By Product & Service, 2020 Vs. 2025 (USD Million)
Figure 7 IVD Quality Control Products Market, By Type, 2020 Vs. 2025 (USD Million)
Figure 8 Market, By Manufacturer, 2020 Vs. 2025 (USD Million)
Figure 9 Third-Party Control Market, By Type, 2020 Vs. 2025 (USD Million)
Figure 10 Market, By End User, 2020 Vs. 2025 (USD Million)
Figure 11 Market, By Technology, 2020 Vs. 2025 (USD Million)
Figure 12 IVD Quality Control Market: Geographic Snapshot
Figure 13 Growing Adoption of Third-Party Controls and Demand for External Quality Assessment are Expected to Drive Market Growth
Figure 14 Immunochemistry Commanded the Largest Share of the APAC Market in 2019
Figure 15 China to Grow at the Highest CAGR During the Forecast Period
Figure 16 Asia Pacific to Witness the Highest Growth During the Forecast Period
Figure 17 Developing Markets to Register Highest Growth During the Forecast Period
Figure 18 US: Number of Laboratories With CLIA Accreditation, By Organization (2018)
Figure 19 Quality Control Products Segment to Witness the Highest Growth During the Forecast Period
Figure 20 Molecular Diagnostics Segment to Witness the Highest Growth in the IVD Quality Control Market During the Forecast Period
Figure 21 Third-Party Controls Segment to Witness Highest Growth During the Forecast Period
Figure 22 Hospitals Dominate the IVD Quality Control Market During the Forecast Period
Figure 23 North America: Market Snapshot
Figure 24 Europe: Market Snapshot
Figure 25 Asia Pacific: Market Snapshot
Figure 26 Key Growth Strategies Adopted By Market Players From 2018 to 2019
Figure 27 Market Ranking Analysis, By Player, 2018
Figure 28 External Quality Assessment Schemes Market Ranking Analysis, By Player, 2018
Figure 29 IVD Quality Control Market (Global) Competitive Leadership Mapping (2019)
Figure 30 Bio-Rad Laboratories: Company Snapshot (2018)
Figure 31 Thermo Fisher Scientific: Company Snapshot
Figure 32 F. Hoffmann-La Roche Ag: Company Snapshot (2018)
Figure 33 Quidel Corporation: Company Snapshot
Figure 34 Abbott Laboratories: Company Snapshot (2018)
Figure 35 Danaher Corporation: Company Snapshot (2018)
Figure 36 Sysmex Corporation: Company Snapshot (2018)
Figure 37 Siemens Healthineers: Company Snapshot (2018)
Figure 38 Bio-Techne Corporation: Company Snapshot (2019)

This study on the global IVD quality control market involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the IVD quality control market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, vice presidents, marketing and sales directors, product managers, business development managers, technology and innovation directors of companies providing quality control products & services, key opinion leaders, and suppliers and distributors. The industry experts from the demand side include hospitals, clinical laboratories, and academic & research institutes.

Following the breakdown of primary respondents

In Vitro Diagnostics (IVD) Quality Control Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product & service, application, manufacturer, end user, and region).

Data Triangulation

After arriving at the market size, the total IVD quality control market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.

Objectives of the Study

  • To define, describe, and forecast the global IVD quality control market by product & service, application, manufacturer, end user, and region
  • To provide detailed information about the factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market in five regions (along with major countries)—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
  • To profile key players in the market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as new product launches; collaborations, partnerships, and agreements; expansions; and R&D activities of the leading players in the global market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific IVD quality control market into Singapore, New Zealand, and other countries
  • Further breakdown of the Rest of Europe market into Belgium, the Netherlands, Switzerland, and other countries
Report Code
MD 4180
Published ON
Mar, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the In Vitro Diagnostics (IVD) Quality Control Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home